U.S. markets open in 2 hours 43 minutes
  • S&P Futures

    3,884.50
    -14.25 (-0.37%)
     
  • Dow Futures

    31,438.00
    -71.00 (-0.23%)
     
  • Nasdaq Futures

    13,228.25
    -51.50 (-0.39%)
     
  • Russell 2000 Futures

    2,257.70
    -17.10 (-0.75%)
     
  • Crude Oil

    60.57
    -0.07 (-0.12%)
     
  • Gold

    1,728.00
    +5.00 (+0.29%)
     
  • Silver

    26.37
    -0.31 (-1.15%)
     
  • EUR/USD

    1.2032
    -0.0028 (-0.23%)
     
  • 10-Yr Bond

    1.4460
    0.0000 (0.00%)
     
  • Vix

    23.43
    -4.52 (-16.17%)
     
  • GBP/USD

    1.3912
    -0.0008 (-0.06%)
     
  • USD/JPY

    106.9300
    +0.2000 (+0.19%)
     
  • BTC-USD

    49,036.05
    +1,675.86 (+3.54%)
     
  • CMC Crypto 200

    986.18
    -0.47 (-0.05%)
     
  • FTSE 100

    6,639.10
    +50.57 (+0.77%)
     
  • Nikkei 225

    29,408.17
    -255.33 (-0.86%)
     

SHAREHOLDER ALERT: Amyris, Inc. (NASDAQ: AMRS) Officers and Directors Under Investigation for Possible Breaches of Fiduciary Duty

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Amyris, Inc. (NASDAQ: AMRS) related to the company's overstatements regarding future royalty payments on its financial statements and false or misleading statements concerning material weaknesses in the company's internal controls.

In 2017, Amyris disclosed that it was addressing a material weakness in its internal controls over financial reporting with a remediation plan. Then, in December 2017, the company licensed its manufacturing plant, requiring the licensee to pay Amyris a $27.5 million use fee as well as royalty fees. However, on April 11, 2019, Amyris announced that material accounting errors were made related to the estimates for recognizing revenue for royalty payments and that it would have to restate several quarterly and annual financial reports. As a result, the price of Amyris's stock fell nearly 24%.

This conduct has exposed the company to securities litigation in the U.S. District Court for the Northern District of California where it is alleged that Amyris misled investors about its efforts to improve internal controls over financial reporting and overstated its royalty revenues through improper revenue recognition. On October 5, 2020, U.S. District Judge Yvonne Gonzalez Rogers denied Amyris's motion to dismiss the case, finding that the plaintiffs met the heightened pleading standards for alleged securities fraud, including alleging facts sufficient to create a "strong inference of scienter," or intent to defraud investors, and that defendants' statements did not qualify as forward-looking statements under the PSLRA's safe harbor.

The Schubert Firm is investigating potential derivative claims based on harm the company has suffered as a result of potential breaches of fiduciary duty by Amyris's officers and directors. For more information, please visit our website at http://www.classactionlawyers.com/Amyris.

If you own stock in Amyris and wish to obtain additional information about your legal rights, please contact us today.

About Schubert Jonckheer & Kolbe LLP
Schubert Jonckheer & Kolbe represents shareholders, employees, and consumers in class actions against corporate defendants, as well as shareholders in derivative actions against their officers and directors. The firm is based in San Francisco, and with the help of co-counsel, litigates cases nationwide.

Contact
Alexandra Green
Schubert Jonckheer & Kolbe LLP
agreen@sjk.law
Tel: 415-299-8207

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-amyris-inc-nasdaq-amrs-officers-and-directors-under-investigation-for-possible-breaches-of-fiduciary-duty-301196638.html

SOURCE Schubert Jonckheer & Kolbe LLP